Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00721357 · ClinicalTrials.gov registry record
Skeletal Muscle Properties and the Metabolic Cost of Walking Post-stroke
A clinical trial, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- 30
- Enrollment target
NCT00721357: Completed study, sponsored by VA Office of Research and Development.
NCT00721357 is a clinical trial that has completed, run by VA Office of Research and Development. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00721357 has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
Of the \~700,000 persons who suffer a stroke each year, only 50% recover the ability to perform unlimited community walking. One mechanism contributing to locomotor dysfunction post-stroke is an increased metabolic cost of walking relative to neurologically healthy individuals 2-4. This increased cost likely limits the amount of walking performed, which further reduces functional capacity, thus contributing to long-term spiral of disability and decreased quality of life in these persons. In addition to increased metabolic cost, increased estimates of mechanical work are also characteristic of hemiparetic walking 2,29. Interestingly, although estimates of mechanical work reflect work done by locomotor muscles, little is known about the impact that peripheral muscle properties have on estimates of mechanical work. Furthermore, questions concerning how these properties relate to the increased metabolic cost of walking remain unanswered. The short-term objective and purpose of the proposed research is to determine the extent to which peripheral muscle characteristics, as well as estimates of muscle mechanical energy expenditure (MMEE), relate to the metabolic cost of walking post-stroke.
Interventions
- BEHAVIORAL Treadmill walking
- OTHER Magnetic resonance spectroscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2008-08 |
| Est. Completion | 2013-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00721357
The ClinicalTrials.gov registry entry for NCT00721357 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Treadmill walking is the first listed.
NCT00721357 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00721357 about?
NCT00721357 is a clinical study titled "Skeletal Muscle Properties and the Metabolic Cost of Walking Post-stroke". Of the \~700,000 persons who suffer a stroke each year, only 50% recover the ability to perform unlimited community walking. One mechanism contributing to locomotor dysfunction post-stroke is an increased metabolic cost of walking relative to neurologically healthy individuals 2-4. This increased co...
What is the current status of trial NCT00721357?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2008-08. Estimated completion is 2013-09.
What interventions are being tested in trial NCT00721357?
The interventions under investigation include: Treadmill walking (BEHAVIORAL), Magnetic resonance spectroscopy (OTHER).
Who is sponsoring clinical trial NCT00721357?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.